Verition Fund Management
ICPT

Verition Fund Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Verition Fund Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-122,600
Closed -$2.83M – 2224
2021
Q1 		$2.83M Buy
122,600
+98,500
+409% +$2.75M 0.03% 325
2020
Q4 		$595K Sell
24,100
-10,500
-30% -$348K 0.01% 622
2020
Q3 		$1.44M Buy
34,600
+30,200
+686% +$1.39M 0.03% 306
2020
Q2 		$211K Buy
+4,400
New +$340K 0.01% 936

Verition Fund Management's ICPT Position: Q4 2023 in Review

Verition Fund Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 11,439 shares — an estimated $212K sold.

Verition Fund Management first reported a position in ICPT in Q3 2014 and held it in 11 quarters. The position peaked at $599K in Q3 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Verition Fund Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 11,439 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $212K.
  • Verition Fund Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 11 quarters.
  • Verition Fund Management's Intercept Pharmaceuticals, Inc. position peaked at $599K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.